azathioprine has been researched along with Developmental Disabilities in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azathioprine (AZA) is recognized among immunosuppressive medications as relatively safe during pregnancy for women with systemic lupus erythematosus (SLE) requiring aggressive treatment." | 3.79 | In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus. ( Ganser, MA; Gordon, C; Hyzy, MA; Marder, W; McCune, WJ; Romero, V; Somers, EC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marder, W | 1 |
| Ganser, MA | 1 |
| Romero, V | 1 |
| Hyzy, MA | 1 |
| Gordon, C | 1 |
| McCune, WJ | 1 |
| Somers, EC | 1 |
| Russo, RA | 1 |
| Katsicas, MM | 1 |
2 other studies available for azathioprine and Developmental Disabilities
| Article | Year |
|---|---|
In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cohort Studies; Developmental Disabilities | 2013 |
Chronic infantile neurological cutaneous and articular syndrome: two new cases with rare manifestations.
Topics: Abnormalities, Multiple; Antirheumatic Agents; Arthritis; Azathioprine; Child, Preschool; Chronic Di | 2001 |